PARAMETRIC PORTFOLIO ASSOCIATES LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 101 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$5,443,000
-42.6%
118,346
-17.3%
0.00%
-40.0%
Q4 2021$9,490,000
+20.7%
143,144
+13.6%
0.01%
+25.0%
Q3 2021$7,865,000
-26.8%
125,980
-2.9%
0.00%
-33.3%
Q2 2021$10,749,000
+47.5%
129,791
+18.1%
0.01%
+50.0%
Q1 2021$7,285,000
-27.2%
109,868
-15.8%
0.00%
-33.3%
Q4 2020$10,012,000
+143.6%
130,485
+36.7%
0.01%
+100.0%
Q3 2020$4,110,000
-17.9%
95,441
-17.7%
0.00%
-25.0%
Q2 2020$5,006,000
+85.8%
115,901
+23.8%
0.00%
+100.0%
Q1 2020$2,694,000
-68.6%
93,654
-30.8%
0.00%
-66.7%
Q4 2019$8,586,000
+103.3%
135,356
-9.7%
0.01%
+100.0%
Q3 2019$4,223,000
+98.4%
149,856
+86.6%
0.00%
+50.0%
Q2 2019$2,128,000
+131.3%
80,302
+60.1%
0.00%
+100.0%
Q1 2019$920,000
+43.3%
50,155
-2.9%
0.00%0.0%
Q4 2018$642,000
-36.2%
51,656
-1.7%
0.00%0.0%
Q3 2018$1,007,000
+2861.8%
52,536
+184.5%
0.00%
Q1 2017$34,000
-87.2%
18,468
-48.7%
0.00%
Q3 2016$265,000
+258.1%
36,002
+157.8%
0.00%
Q2 2016$74,00013,9670.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders